Senor SRL
The score of Senor shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +16 % Total assets -7 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Senor's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 57,636 € | ||||
| Equity | 763,092 € | ||||
| Cash | 51,104 € | ||||
| EBITDA | 154,369 € | ||||
| Total assets | 939,016 € |
Filed annual accounts
- Year ended 31 Mar 2025filed on 31 Oct 2025
- Year ended 31 Mar 2024filed on 31 Oct 2024
- Year ended 31 Mar 2023filed on 27 Nov 2023
- Year ended 31 Mar 2022filed on 30 Nov 2022
- Year ended 31 Mar 2021filed on 15 Dec 2021
Senor's financial analysis
- Solvency81.3%sector median: 46.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Senor
Senor's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0886.286.822
- VAT number
- BE0886286822
- Peppol
- Registered · 0208:0886286822 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 10 Jan 2007
- Registered office
- 9600 Ronse
- Latest accounts
- 2025 · filed on 31 Oct 2025
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Senor (SRL) has been based in Ronse since 2007, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net profit of 57,636 € and equity of 763,092 €; its revenue is not published. Its solvency stands at 81.3%, above the median of its sector (46.0%).
Companies similar to Senor
Companies in the same business, of comparable size and area, outside its group.
- Dental SUD Retail sale of medical and orthopaedic goods Namur · balance sheet 34,848 €
- NEW Davigo Retail sale of medical and orthopaedic goods Forest · balance sheet 933,610 €
- A.Brasseur Retail sale of medical and orthopaedic goods Brussels · balance sheet €1.03m
- Point Sante Retail sale of medical and orthopaedic goods La Louvière · balance sheet €1.05m
- Apotheek DE Sterre Retail sale of pharmaceutical products Ghent · balance sheet 863,882 €
- Medical Appliance Company Wholesale of pharmaceutical and medical goods Aartselaar · balance sheet 937,841 €
- Valimara Wholesale of pharmaceutical and medical goods Zedelgem · balance sheet 637,045 €
- Gescab Retail sale of medical and orthopaedic goods Chaudfontaine · balance sheet 790,289 €
Frequently asked questions about Senor
What is the revenue of Senor?
Senor files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Senor?
In Belgium, the VAT number is the company number prefixed with BE: BE0886286822 for Senor, if the company is VAT-registered. Its company number (CBE) is 0886.286.822.
Where is the registered office of Senor?
According to the CBE register, the registered office of Senor is in 9600 Ronse.
What is the equity of Senor?
At the close of the 2025 financial year, the equity of Senor amounts to 763,092 €, a solvency of 81.3% of total assets.
Who manages Senor?
The register lists 3 active mandates at Senor. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Senor
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →